ABVC Biopharma Inc (ABVC) stock news · rev $796.0K
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
This ABVC news page leads with what ABVC Biopharma Inc filed — not a scraped headline mill.
No cached 8-K sentence for ABVC yet. We will not pad this page with generic market recap.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.3M. ABVC currently screens at market cap $35.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ABVC stock page; for the tape open the quote page.
Not investment advice.